Laboratory Case Series #2
Interpreting Post-Transfusion Hematologic Changes: A Medical Laboratory Science Perspective
This article presents a laboratory-based analysis of hematological changes observed in a 55-year-old patient with a known diagnosis of Non-Hodgkin Lymphoma (LNH) and anemia, who underwent Packed Red Cell (PRC) transfusion.
The discussion is framed strictly from a Medical Laboratory Science perspective. No diagnoses are made, and all interpretations are intended to support clinical correlation.
Summary of Laboratory Results
| Parameter | Result |
|---|---|
| Date | 16/02/2026 |
| Hemoglobin (g/dL) | 8.9 |
| Hematocrit (%) | 28.7 |
| Leukocytes (×10³/µL) | 5.39 |
| Platelets (×10³/µL) | 230 |
| Erythrocytes (×10⁶/µL) | 2.77 |
| Post-PRC (17/02/2026) | |
| Hemoglobin (g/dL) | 9.8 |
| Hematocrit (%) | 31.9 |
| Leukocytes (×10³/µL) | 4.90 |
| Platelets (×10³/µL) | 196 |
| Erythrocytes (×10⁶/µL) | 3.03 |
Pathomedical Explanation: Hemoglobin Elevation
The observed increase in hemoglobin, hematocrit, and erythrocyte count after PRC transfusion is an expected and desired laboratory outcome.
PRC units contain concentrated red blood cells with minimal plasma. When transfused, they directly increase the patient’s circulating red cell mass.
From a laboratory physiology standpoint:
- Each unit of PRC provides mature erythrocytes capable of immediate oxygen transport.
- Unlike endogenous erythropoiesis, this process does not depend on bone marrow activity.
- The hemoglobin rise is therefore rapid and measurable within 12–24 hours.
In patients with hematologic disorders such as LNH, anemia may be multifactorial (e.g., marrow infiltration, chronic inflammation, or treatment effects). PRC transfusion temporarily compensates for reduced red cell availability, which is reflected clearly in post-transfusion CBC results.
Pathomedical Explanation: Why Platelets May Decrease
Although platelet count remains within normal laboratory limits, a decrease from 230 → 196 ×10³/µL is noted. This finding is not uncommon following PRC transfusion.
1️⃣ Hemodilution Effect
PRC transfusion increases intravascular volume without adding platelets.
- The added red cell mass slightly expands plasma volume.
- Platelets become relatively diluted in circulation.
- This produces a numerical decrease without actual platelet loss.
2️⃣ Platelet Consumption and Redistribution
In patients with systemic illness or hematologic malignancy, platelets may undergo transient redistribution due to:
- Splenic sequestration
- Low-grade inflammatory activation
- Endothelial interaction
These mechanisms can mildly influence platelet counts without indicating hemorrhagic risk or marrow failure.
3️⃣ Lack of Platelet Replacement in PRC Units
PRC products are platelet-poor by design. Therefore:
- Hemoglobin increases significantly
- Platelets do not receive proportional support
This explains why red cell parameters improve more prominently than platelet values after transfusion.
Laboratory Significance of This Pattern
- The combination of rising Hb with mildly reduced platelet count represents a physiological post-transfusion pattern.
- No critical platelet thresholds are crossed.
- Interpretation should rely on trend analysis rather than isolated values.
This reinforces the importance of documenting transfusion status when interpreting post-analytical CBC data.
Key Takeaways
- Hemoglobin elevation reflects effective PRC transfusion response
- Platelet decrease is commonly due to dilution and redistribution
- Findings are laboratory-explainable and clinically correlatable
- Serial monitoring remains essential in hematologic conditions
References
- Packed Red Cell (PRC) transfusion is commonly used to increase hemoglobin levels in patients with anemia by providing concentrated red blood cells. Available at: UGM Medical Journal – PRC and Hemoglobin Levels
- Girianto PW, Mulyasari MW. The Effectiveness of Packed Red Cell (PRC) Transfusion on Hemoglobin Levels. Journal of Ners and Midwifery. Available at: Journal Article
- Dilutional thrombocytopenia may occur after transfusion of non-platelet blood components such as PRC, which dilute circulating platelets. Available at: ClinicalGate – Blood Therapy
- Massive transfusion of packed red blood cells or other blood products can reduce platelet concentration through dilutional effects. Available at: Transfusion Medicine Review
- Guidelines on platelet transfusion and management of thrombocytopenia in transfusion medicine. Available at: PubMed – Platelet Transfusion Guidance